Detalles de la búsqueda
1.
Comparing the latent state-trait structure of the PANSS in cariprazine-medicated and placebo-controlled patients with acute schizophrenia.
Eur Arch Psychiatry Clin Neurosci
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38553640
2.
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine.
Pharmacopsychiatry
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710207
3.
The efficacy and safety of cariprazine in the early and late stage of schizophrenia: a post hoc analysis of three randomized, placebo-controlled trials.
CNS Spectr
; 28(1): 104-111, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35012696
4.
The burden of caring for someone with schizophrenia: A cross country report from Bulgaria, the Czech Republic, Hungary and Russia.
Psychiatr Hung
; 36(4): 546-556, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34939572
5.
[Cariprazine, a new type - dopamine D3 receptor preferring - partial agonist atypical antipsychotic for the treatment of schizophrenia and the primary negative symptoms]. / Kariprazin, egy új típusú dopamin D3 receptort preferáló parciális agonista atípusos antipszichotikum a szkizofrénia és primer negatív tüneteinek kezelésére.
Neuropsychopharmacol Hung
; 21(3): 103-118, 2019 Sep.
Artículo
en Húngaro
| MEDLINE | ID: mdl-31537751
6.
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.
Lancet
; 389(10074): 1103-1113, 2017 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28185672
7.
Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone.
Schizophr Res
; 261: 24-30, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37688910
8.
What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial.
Front Psychiatry
; 13: 816339, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546918
9.
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety.
Adv Ther
; 38(7): 3652-3673, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34091867
10.
Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System.
Front Psychiatry
; 12: 803208, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34970175
11.
Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia.
Front Psychiatry
; 12: 770234, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35069278
12.
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies.
Neuropsychiatr Dis Treat
; 17: 957-970, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33854317
13.
The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study.
Int Clin Psychopharmacol
; 36(3): 154-161, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33560040
14.
Cariprazine and akathisia, restlessness, and extrapyramidal symptoms in patients with bipolar depression.
J Affect Disord
; 288: 191-198, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33915374
15.
Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms.
Eur Psychiatry
; 65(1): e18, 2021 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34641986
16.
Cognitive estimation in aged patients with major depressive disorder.
Psychiatry Res
; 176(1): 26-9, 2010 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20064666
17.
Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data.
Front Psychiatry
; 11: 61, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32194443
18.
Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation.
Neuropsychiatr Dis Treat
; 15: 2537-2550, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31507322
19.
Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia.
Neuropsychopharmacology
; 44(9): 1589-1596, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30836381
20.
Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data.
Schizophr Res
; 204: 282-288, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30172595